Month: August 2023

Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women

Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes

Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenous Tecentriq, including certain types of lung,...

Masimo Corporation (MASI) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Masimo Corporation Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--$MASI #MasimoCorporation--Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons who purchased...

error: Content is protected !!